H-1B filings

Does Kite Pharma Inc. sponsor H-1B?

Yes, according to public filings. Kite Pharma Inc. filed 137 H-1B labor condition applications in fiscal years 2024-2026, including 33 in fiscal year 2026.

USCIS approved 81 H-1B petitions for this employer in fiscal years 2024-2026.

This page uses public government filings. A filing does not guarantee that the employer will sponsor you. This information is not legal advice.

Status on October 22, 2026: USCIS does not collect the $100,000 payment on new H-1B petitions for workers outside the U.S. while court orders stand. Appeals are pending, so this can change. USCIS H-1B FAQ

Labor condition applications by fiscal year

Fiscal yearFiledCertifiedWorkers
2026333333
20255454276
20245050442

An employer files a labor condition application with the Department of Labor before it files an H-1B petition. A certified application is not an approved visa. The U.S. fiscal year runs from October 1 to September 30.

USCIS decisions on H-1B petitions by fiscal year

Fiscal yearNew: approvedNew: deniedContinuing: approvedContinuing: denied
202640140
2025110251
202470200

New petitions are for first H-1B employment. Continuing petitions are for extensions and for workers who change employers.

Typical roles and wage ranges

Job titleApplicationsWage range per yearMedian
Associate Scientist, Cell Biology4$99,715 - $125,278$120,078
Sr. Research Associate I, Cell Biology4$94,955 - $101,816$96,795
Manager, IT Business Analysis3$125,360 - $149,781$146,994
Cell Therapy Specialist I3$56,560 - $57,760$56,560
Sr. Manager, Statistical Programming3$137,600 - $148,117$141,680
Senior Manager, Statistical Programming3$145,371 - $148,117$148,117
Supply Chain Specialist III3$71,760 - $97,240$86,674
Research Scientist, Bioinformatics3$95,014 - $119,040$119,040
Assoc Director, Biostatistics2$167,440 - $167,440$167,440
Qc Specialist II2$87,360 - $87,942$87,942

Wages are the rates the employer stated in its applications. Actual pay can differ.

Top locations

Sources

Data release 2026q3, built on October 23, 2026.